(VTYX) Ventyx Biosciences - Performance -4.6% in 12m
VTYX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-69.32%
#142 in Peer-Group
Rel. Strength
32.43%
#5186 in Stock-Universe
Total Return 12m
-4.59%
#94 in Peer-Group
Total Return 5y
-90.10%
#160 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 3.20 USD |
| 52 Week Low | 0.84 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 45.14 |
| Buy/Sell Signal +-5 | 1.12 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: VTYX (-4.6%) vs XLV (-4.6%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
3.27% | 140% | 332% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
4.24% | 16.8% | 78.4% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
1.94% | -14.1% | 396% | 63.3 | 35.6 | 1.19 | 58.2% | 18.9% |
| NOVN SW Novartis |
0.79% | 3.78% | 49.4% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-6.42% | 2.63% | 46.3% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-4.86% | -7.48% | 108% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| AZN NASDAQ AstraZeneca |
-4.86% | -8.38% | 44% | 28.5 | 15.7 | 0.95 | 52.7% | 22.3% |
| IPN PA Ipsen |
-2.2% | -6.85% | 38.7% | 24.1 | 10.2 | 0.73 | -6.40% | -6.33% |
Performance Comparison: VTYX vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for VTYX
| Total Return (including Dividends) | VTYX | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 4.52% | 2.14% | 5.25% |
| 3 Months | 121.28% | 0.64% | 24.13% |
| 12 Months | -4.59% | -4.57% | 14.15% |
| 5 Years | -90.10% | 42.89% | 111.83% |
| Trend Score (consistency of price movement) | VTYX | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -44.2% | 35.8% | 81% |
| 3 Months | 91.7% | -28.5% | 96.9% |
| 12 Months | -48.4% | -74.5% | 44.9% |
| 5 Years | -68.3% | 87.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th68.50 | 2.33% | -0.69% |
| 3 Month | %th96.00 | 119.87% | 78.26% |
| 12 Month | %th54.50 | -0.01% | -16.42% |
| 5 Years | %th24.00 | -90.98% | -93.20% |
FAQs
Does Ventyx Biosciences (VTYX) outperform the market?
No,
over the last 12 months VTYX made -4.59%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.57%.
Over the last 3 months VTYX made 121.28%, while XLV made 0.64%.
Performance Comparison VTYX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
VTYX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -12.8% | -0.7% | -19.7% | -19% |
| US NASDAQ 100 | QQQ | -12.6% | -0.8% | -20.4% | -17% |
| German DAX 40 | DAX | -10.7% | 5.9% | -31.9% | -33% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -12.7% | 1.3% | -23.1% | -25% |
| Hongkong Hang Seng | HSI | -12.4% | -1.5% | -39.2% | -43% |
| India NIFTY 50 | INDA | -11% | 1.1% | -20% | -4% |
| Brasil Bovespa | EWZ | -15.3% | -4.3% | -44.8% | -15% |
VTYX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -11.4% | -1.4% | -23.8% | -29% |
| Consumer Discretionary | XLY | -12.3% | 1.4% | -12.1% | -22% |
| Consumer Staples | XLP | -13.1% | 3.9% | -21.4% | -13% |
| Energy | XLE | -13.1% | -2.5% | -15.6% | -4% |
| Financial | XLF | -13.5% | -0.6% | -24.6% | -35% |
| Health Care | XLV | -12.3% | 2.4% | -12.4% | -0% |
| Industrial | XLI | -12.9% | 0.3% | -27.6% | -30% |
| Materials | XLB | -15.1% | 0.2% | -24.2% | -11% |
| Real Estate | XLRE | -12.8% | 3.5% | -19.4% | -17% |
| Technology | XLK | -13.6% | -4.2% | -22% | -16% |
| Utilities | XLU | -11.7% | 2.7% | -22.9% | -27% |
| Aerospace & Defense | XAR | -10.7% | -2.5% | -38.3% | -54% |
| Biotech | XBI | -13.8% | 1.2% | -6.5% | 2% |
| Homebuilder | XHB | -15.3% | -2.5% | -12.5% | -10% |
| Retail | XRT | -15.4% | -0.5% | -15.4% | -16% |
VTYX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -13.7% | -3.92% | -11.3% | 3% |
| Natural Gas | UNG | -3.3% | 14.3% | -2.9% | -2% |
| Gold | GLD | -13.1% | 5.7% | -40.4% | -44% |
| Silver | SLV | -13.8% | -2.4% | -37.1% | -22% |
| Copper | CPER | -11.9% | -0.1% | -36.8% | -15% |
VTYX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -11% | 3.5% | -16.3% | -3% |
| iShares High Yield Corp. Bond | HYG | -11.6% | 2.9% | -18.6% | -15% |